Indication
MET Gene Mutation
2 clinical trials
4 products
2 drugs
Clinical trial
Treatment Strategies and Survival Outcome for Non-small Cell Lung Cancer With Oncogenic Mutation.Status: Recruiting, Estimated PCD: 2026-12-24
Drug
OsimertinibProduct
AlectinibProduct
CrizotinibProduct
SavolitinibDrug
AN0025Clinical trial
Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesStatus: Recruiting, Estimated PCD: 2025-08-01
Product
Gene test